BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3126615)

  • 1. [Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)].
    Guddat HM; Schnorr D; Dörner G; Stahl F; Rohde W
    Z Urol Nephrol; 1987 Dec; 80(12):665-8. PubMed ID: 3126615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conservative therapy of prostate cancer using Turisteron].
    Schnorr D; Dörner G; Stahl F; Rohde W; Guddat HM
    Z Urol Nephrol; 1987 Mar; 80(3):149-57. PubMed ID: 3111122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].
    Stahl F; Schnorr D; Rohde W; Dörner G
    Z Urol Nephrol; 1987 Mar; 80(3):135-8. PubMed ID: 3604472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of ethinyl estradiol sulfonate in conservative therapy of prostate cancer].
    Guddat HM; Schnorr D; Dörner G; Stahl F; Rhode W
    Z Urol Nephrol; 1987 Mar; 80(3):125-33. PubMed ID: 3604471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
    Tomić R
    Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reference values of FSH, LH, total testosterone, free testosterone, 17-beta-estradiol and SHBG in healthy children in Zaragoza].
    Cortés Blanco A; Ferrández Longás A; Mayayo Dehesa E; Labarta Aizpún JI
    An Esp Pediatr; 1999 Aug; 51(2):159-66. PubMed ID: 10495503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH.
    Bruheim K; Svartberg J; Carlsen E; Dueland S; Haug E; Skovlund E; Tveit KM; Guren MG
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):722-7. PubMed ID: 18262088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
    Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic results with tamoxifen in oligospermia. II. Hormonal analysis and semen parameters].
    Schieferstein G; Adam W; Armann J; Bantel E; Cörlin R; Egenrieder H; Fierlbeck G; Hook B; Schiek A; Schubring G
    Andrologia; 1987; 19(3):333-41. PubMed ID: 3115143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
    Kobayashi T; Nishizawa K; Mitsumori K
    Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a dynamic test with HCG for evaluation of endocrine function in gonads of men with chronic alcohol abuse].
    Kiełkiewicz D; Medraś M; Dolna M
    Pol Merkur Lekarski; 2001 Feb; 10(56):85-8. PubMed ID: 11320584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male patients with partial androgen insensitivity syndrome: a longitudinal follow-up of growth, reproductive hormones and the development of gynaecomastia.
    Hellmann P; Christiansen P; Johannsen TH; Main KM; Duno M; Juul A
    Arch Dis Child; 2012 May; 97(5):403-9. PubMed ID: 22412043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Testosterone and SHBG levels in blood serum in women with anorexia nervosa].
    Skałba P; Zieba M; Olejek A
    Wiad Lek; 2001; 54(9-10):532-6. PubMed ID: 11816297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
    Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sex-hormone-binding globulin and free sex steroid hormones in hyperandrogenic anovulation.
    Ohsawa M; Asai M; Masahashi T; Narita O; Tomoda Y; Matsui N
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2081-8. PubMed ID: 2947958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of prostatic cancer with the orally active depot estrogen ethinylestradiol sulfonate (Turisteron).
    Dörner G; Schnorr D; Stahl F; Rohde W
    Exp Clin Endocrinol; 1985 Dec; 86(2):190-6. PubMed ID: 3912197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
    Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
    J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testosterone, FSH and LH level in the serum of patients with prostatic neoplasms, treated with female hormones].
    Weidner W; Krause W; Pust R; Engstfeld J; Rothauge CF
    Helv Chir Acta; 1978 Jul; 45(3):287-90. PubMed ID: 701064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.